Oncostatin M: a pleiotropic cytokine in the central nervous system

被引:75
作者
Chen, SH
Benveniste, EN
机构
[1] Univ Alabama Birmingham, Dept Cell Biol, MCLM 386, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Cell Biol, MCLM 395, Birmingham, AL 35294 USA
关键词
oncostatin M; signal transduction; central nervous system; brain tumors; glial cells;
D O I
10.1016/j.cytogfr.2004.06.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oncostatin M (OSM), a member of the interleukin-6 (IL-6) cytokine family, has yet to be well studied, especially in the context of the central nervous system (CNS). The biological functions of OSM are complex and variable, depending on the cellular microenvironment. Inflammatory responses and tumor development are among two of the major events that OSM is involved in. Although OSM levels remain low in the normal CNS. elevated expression occurs in pathological conditions. Therefore, it is crucial to understand the regulation of OSM to control its expression and/or its effects. Accumulating data demonstrate that OSM binds to specific receptor complexes, then activates two major signaling pathways: Janus Kinase-Signal Transducers and Activators of Transcription (JAK-STAT) and Mitogen-Activated Protein Kinase (MAPK), to regulate downstream events. In this review, we focus on the biological functions of OSM, the signaling pathways of OSM in the CNS. and OSM involvement in CNS diseases. (C) 2004, Elsevier Ltd. All rights reserved.
引用
收藏
页码:379 / 391
页数:13
相关论文
共 120 条
  • [1] Suppressors of cytokine signalling (SOCS) in the immune system
    Alexander, WS
    [J]. NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) : 410 - 416
  • [2] Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes
    Aloisi, F
    Ria, F
    Adorini, L
    [J]. IMMUNOLOGY TODAY, 2000, 21 (03): : 141 - 147
  • [3] Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
    Barleon, B
    Sozzani, S
    Zhou, D
    Weich, HA
    Mantovani, A
    Marme, D
    [J]. BLOOD, 1996, 87 (08) : 3336 - 3343
  • [4] Immunological aspects of microglia: relevance to Alzheimer's disease
    Benveniste, EN
    Nguyen, VT
    O'Keefe, GM
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2001, 39 (5-6) : 381 - 391
  • [5] Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor α, and oncostatin M receptor β by distinct mechanisms
    Blanchard, F
    Wang, YP
    Kinzie, E
    Duplomb, L
    Godard, A
    Baumann, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) : 47038 - 47045
  • [6] Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor
    Bousquet, C
    Susini, C
    Melmed, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (09) : 1277 - 1285
  • [7] Cytokines in autoimmunity
    Brennan, FM
    Feldmann, M
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (06) : 872 - 877
  • [8] BROWN TJ, 1987, J IMMUNOL, V139, P2977
  • [9] Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M
    Broxmeyer, HE
    Bruns, HA
    Zhang, SM
    Cooper, S
    Hangoc, G
    McKenzie, ANJ
    Dent, AL
    Schindler, U
    Naeger, LK
    Hoey, T
    Kaplan, MH
    [J]. IMMUNITY, 2002, 16 (06) : 815 - 825
  • [10] BRUCE AG, 1992, J IMMUNOL, V149, P1271